Site-selective modification strategies in antibody–drug conjugates

SJ Walsh, JD Bargh, FM Dannheim… - Chemical Society …, 2021 - pubs.rsc.org
Antibody–drug conjugates (ADCs) harness the highly specific targeting capabilities of an
antibody to deliver a cytotoxic payload to specific cell types. They have garnered …

Enzymes as green catalysts for precision macromolecular synthesis

S Shoda, H Uyama, J Kadokawa, S Kimura… - Chemical …, 2016 - ACS Publications
The present article comprehensively reviews the macromolecular synthesis using enzymes
as catalysts. Among the six main classes of enzymes, the three classes, oxidoreductases …

Characterization of therapeutic antibodies and related products

A Beck, E Wagner-Rousset, D Ayoub… - Analytical …, 2013 - ACS Publications
Here, we review the current state of the art in analytical and structural methods used to
characterize therapeutic monoclonal antibodies (mAbs) and derivatives. First, a general …

Emerging principles for the therapeutic exploitation of glycosylation

M Dalziel, M Crispin, CN Scanlan, N Zitzmann… - Science, 2014 - science.org
Background Glycoproteins and glycolipids exist as an ensemble of glycosylated variants, or
glycoforms. Specific glycoforms are directly modulated by microenvironmental cues and play …

Chemoenzymatic methods for the synthesis of glycoproteins

C Li, LX Wang - Chemical reviews, 2018 - ACS Publications
Glycosylation is one of the most prevalent posttranslational modifications that profoundly
affects the structure and functions of proteins in a wide variety of biological recognition …

Oligosaccharide synthesis and translational innovation

L Krasnova, CH Wong - Journal of the American Chemical Society, 2019 - ACS Publications
The translation of biological glycosylation in humans to the clinical applications involves
systematic studies using homogeneous samples of oligosaccharides and glycoconjugates …

Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions

W Huang, J Giddens, SQ Fan, C Toonstra… - Journal of the …, 2012 - ACS Publications
The fine structures of Fc N-glycans can modulate the effector functions of IgG antibodies. It
has been demonstrated that lack of the core fucose on the Fc N-glycans leads to drastic …

Chemoenzymatic conjugation of toxic payloads to the globally conserved N-glycan of native mAbs provides homogeneous and highly efficacious antibody–drug …

R Van Geel, MA Wijdeven, R Heesbeen… - Bioconjugate …, 2015 - ACS Publications
A robust, generally applicable, nongenetic technology is presented to convert monoclonal
antibodies into stable and homogeneous ADCs. Starting from a native (nonengineered) …

A common glycan structure on immunoglobulin G for enhancement of effector functions

CW Lin, MH Tsai, ST Li, TI Tsai… - Proceedings of the …, 2015 - National Acad Sciences
Antibodies have been developed as therapeutic agents for the treatment of cancer, infection,
and inflammation. In addition to binding activity toward the target, antibodies also exhibit …

The ENGases: versatile biocatalysts for the production of homogeneous N-linked glycopeptides and glycoproteins

AJ Fairbanks - Chemical Society Reviews, 2017 - pubs.rsc.org
The endo-β-N-acetylglucosaminidases (ENGases) are an enzyme class (EC 3.2. 1.96)
produced by a range of organisms, ranging from bacteria, through fungi, to higher order …